Orthopedics, Arthroplasty and Rheumatology

Biologics in Arthritis Management

Biologics in Arthritis Management focuses on the transformative role of biologic therapies in treating inflammatory joint diseases like rheumatoid arthritis. TNF inhibitors, IL-6 inhibitors, and Janus kinase (JAK) inhibitors are helping to target specific pathways involved in inflammation, offering more effective management compared to traditional medications. These therapies not only reduce pain and swelling but also slow disease progression and prevent joint damage. Biologics can be tailored to individual patients, providing personalized treatment options for better outcomes. New biosimilars are expanding access to biologic therapies at a lower cost. As research continues, combination therapies and regenerative treatments like stem cell injections are also showing promise in further enhancing the management of arthritis. Biologics are revolutionizing arthritis care, improving quality of life and long-term joint function for patients.